Enable Accessibility Enable Accessibility

Takeda Announces Candidates for New Directors

May 15, 2020

Osaka, Japan, May 13, 2020, --- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has decided the candidates for new Directors which will be proposed to the 144th Ordinary General Meeting of Shareholders in June 2020. The candidates are as follows;

 

  1. Candidates for Non-Audit and Supervisory Committee Directors

Name

Category

Current Role

Christophe Weber

Internal

Existing

Representative Director,
President & Chief Executive Officer

Masato Iwasaki

Internal

Existing

Director, President, Japan Pharma Business Unit

Andrew Plump

Internal

Existing

Director, President, Research & Development

Constantine Saroukos

Internal

Existing

Director, Chief Financial Officer

Masahiro Sakane

External

Existing

External Director, Chair of the Board Meeting

Olivier Bohuon

External

Existing

External Director

Jean-Luc Butel

External

Existing

External Director

Ian Clark

External

Existing

External Director

Yoshiaki Fujimori

External

Existing

External Director

Steven Gillis

External

Existing

External Director

Shiro Kuniya

External

Existing

External Director

Toshiyuki Shiga

External

Existing

External Director

 

  1. Candidates for Audit and Supervisory Committee Directors

Name

Category

Current Role

Yasuhiko Yamanaka

Internal

Existing

Director, Full-time Audit & Supervisory Committee member

Koji Hatsukawa

External

Existing

External Director, Chairperson of Audit & Supervisory Committee

Emiko Higashi

External

Existing

External Director, Audit & Supervisory Committee member

Michel Orsinger

External

Existing

External Director, Audit & Supervisory Committee member

 



Media Contact:
Kazumi Kobayashi
kazumi.kobayashi@takeda.com
+81 (0) 3-3278-2095